Clinical characteristics of Japanese lung cancer patients with human immunodeficiency virus infection

International Journal of Clinical Oncology

Volumn 17, Issue 5, 2012, Pages 462-469

  Okuma, Yusuke ^a   Yanagisawa, Naoki ^a   Takagi, Yusuke ^a   Hosomi, Yukio ^a   Suganuma, Akihiko ^a   Imamura, Akifumi ^a   Iguchi, Mari ^a   Okamura, Tatsuru ^a   Ajisawa, Atsushi ^a   Shibuya, Masahiko ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Epidermal growth factor receptor mutation; Highly active antiretroviral therapy; Human immunodeficiency virus; Lung cancer; Non AIDS defining cancer; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; CARBOPLATIN; CISPLATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IRINOTECAN; PACLITAXEL; PEMETREXED; VIRUS RNA;

ADULT; ADVANCED CANCER; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CD4 LYMPHOCYTE COUNT; CHEMORADIOTHERAPY; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED RADIOTHERAPY; DERMATITIS; DIARRHEA; DRUG FATALITY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ESOPHAGITIS; FEBRILE NEUTROPENIA; GENE MUTATION; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INOPERABLE CANCER; JAPANESE; LATENT PERIOD; LEUKOPENIA; LOW DRUG DOSE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MEDICAL RECORD REVIEW; NAUSEA; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; RADIATION DERMATITIS; RETROSPECTIVE STUDY; SURVIVAL TIME; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; VIRUS LOAD; VOMITING;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84869492921     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-011-0316-1     Document Type: Article

References (52)

1. Crum-Cianflone N, Hullsiek KH, Marconi V et al (2009) Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS 23:41-50
2. Engels EA, Brock MV, Chen J et al (2006) Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol 24:1383-1388
3. Engels EA, Pfeiffer RM, Goedert JJ et al (2006) Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 20:1645-1654
4. Herida M, Mary-Krause M, Kaphan R et al (2003) Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 21:3447-3453
5. Sridhar KS, Flores MR, Raub WA Jr et al (1992) Lung cancer in patients with human immunodeficiency virus infection compared with historic control subjects. Chest 102:1704-1708
6. Tirelli U, Spina M, Sandri S et al (2000) Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors. Cancer 88:563-569
7. Vyzula R, Remick SC (1996) Lung cancer in patients with HIV infection. Lung Cancer 15:325-339
8. Azzoli CG, Baker S Jr, Temin S et al (2009) American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol 27:6251-6266
9. Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 311:899-909
10. Kirk GD, Merlo C, O'Driscoll P et al (2007) HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis 45:103-110
11. Powles T, Bower M (2004) HIV and the risk of lung cancer. J Clin Oncol 22:1348-1349 (author reply 1349-1350)
12. Petoumenos K, Hui E, Kumarasamy N et al (2010) Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors. J Int AIDS Soc 13:51
13. Lavole A, Chouaid C, Baudrin L et al (2009) Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer. Lung Cancer 65:345-350
14. Frisch M, Biggar RJ, Engels EA et al (2001) Association of cancer with AIDS-related immunosuppression in adults. JAMA 285:1736-1745
15. Cinti SK, Gandhi T, Riddell J 4th (2008) Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier? AIDS Read 18(18-20):26-32
16. Grulich AE, van Leeuwen MT, Falster MO et al (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370:59-67
17. Wistuba II, Behrens C, Milchgrub S et al (1998) Comparison of molecular changes in lung cancers in HIV-positive and HIVindeterminate subjects. JAMA 279:1554-1559
18. Bower M, Powles T, Nelson M et al (2003) HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS 17:371-375
19. Samet JM, Wiggins CL, Humble CG et al (1988) Cigarette smoking and lung cancer in New Mexico. Am Rev Respir Dis 137:1110-1113
20. The National Lung Screening Trial Research Team (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. doi:10.1056/NEJMoa1102873
21. White CS, Haramati LB, Elder KH et al (1995) Carcinoma of the lung in HIV-positive patients: findings on chest radiographs and CT scans. AJR Am J Roentgenol 164:593-597
22. Grubb JR, Moorman AC, Baker RK et al (2006) The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy. AIDS 20:1095-1107
23. Brock MV, Hooker CM, Engels EA et al (2006) Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr 43:47-55
24. Chaturvedi AK, Pfeiffer RM, Chang L et al (2007) Elevated risk of lung cancer among people with AIDS. AIDS 21:207-213
25. Pakkala S, Ramalingam SS (2010) Lung cancer in HIV-positive patients. J Thorac Oncol 5:1864-1871
26. Levine AM, Seaberg EC, Hessol NA et al (2010) HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study. J Clin Oncol 28:1514-1519
27. Pakkala S, Chen Z, Rimland D et al (2011) Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy. Cancer. doi:10.1002/cncr.26242
28. Cadranel J, Garfield D, Lavole A et al (2006) Lung cancer in HIV infected patients: facts, questions and challenges. Thorax 61:1000-1008
29. Lavole A, Epaud C, Rosencher L et al (2007) Lung cancer in HIV-positive patients. Rev Pneumol Clin 63:167-175
30. Cotter SE, Grigsby PW, Siegel BA et al (2006) FDG-PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys 65:720-725
31. Chak LY, Gill PS, Levine AM et al (1988) Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Clin Oncol 6:863-867
32. Cooper JS, Fried PR, Laubenstein LJ (1984) Initial observations of the effect of radiotherapy on epidemic Kaposi's sarcoma. JAMA 252:934-935
33. Makinson A, Pujol JL, Le Moing V et al (2010) Interactions between cytotoxic chemotherapy and antiretroviral treatment in human immunodeficiency virus-infected patients with lung cancer. J Thorac Oncol 5:562-571
34. Rowinsky E, Donehower R (1997) Pharmacology of cancer chemotherapy - antimicrotubule agents. In: De Vita VT, Hellman S, Rosember SA (eds) Cancer principles and practice of oncology, 5th edn. Lippincott-Raven, Philadelphia, pp 467-483
35. Aberg JA (2009) Cardiovascular complications in HIV management: past, present, and future. J Acquir Immune Defic Syndr 50:54-64
36. Huang J, Meixner L, Fernandez S et al (2009) A double-blinded, randomized controlled trial of zoledronate therapy for HIVassociated osteopenia and osteoporosis. AIDS 23:51-57
37. Bolland MJ, Grey AB, Horne AM et al (2007) Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial. J Clin Endocrinol Metab 92:1283- 1288
38. Silverberg MJ, Neuhaus J, Bower M et al (2007) Risk of cancers during interrupted antiretroviral therapy in the SMART study. AIDS 21:1957-1963
39. Kivisto KT, Kroemer HK, Eichelbaum M (1995) The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. Br J Clin Pharmacol 40:523-530
40. Karp J, Profeta G, Marantz PR et al (1993) Lung cancer in patients with immunodeficiency syndrome. Chest 103:410-413
41. D'Jaen GA, Pantanowitz L, Bower M et al (2010) Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. Clin Lung Cancer 11:396-404
42. Spano JP, Massiani MA, Bentata M et al (2004) Lung cancer in patients with HIV Infection and review of the literature. Med Oncol 21:109-115
43. Hakimian R, Fang H, Thomas L et al (2007) Lung cancer in HIVinfected patients in the era of highly active antiretroviral therapy. J Thorac Oncol 2:268-272
44. Massera F, Rocco G, Rossi G et al (2000) Pulmonary resection for lung cancer in HIV-positive patients with low (\200 lymphocytes/mm(3)) CD4(?) count. Lung Cancer 29:147-149
45. Ou SH, Ziogas A, Zell JA (2009) Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status. J Thorac Oncol 4:1083-1093
46. Maemondo M, Inoue A, Kobayashi K et al (2010) Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 362:2380-2388
47. Mitsudomi T, Morita S, Yatabe Y et al (2009) Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol 11:121-128
48. Rosell R, Moran T, Queralt C et al (2009) Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 361:958-967
49. Rosell R, Moran T, Carcereny E et al (2009) Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain. Clin Transl Oncol 12:75-80
50. Antoniou T, Tseng AL (2005) Interactions between antiretrovirals and antineoplastic drug therapy. Clin Pharmacokinet 44:111-145
51. Alshafie MT, Donaldson B, Oluwole SF (1997) Human immunodeficiency virus and lung cancer. Br J Surg 84:1068-1071
52. Bertolaccini L, Lybéris P, Soncini S et al (2008) Clinical characteristic lung cancer in HIV-infected patients. Cancer Therapy 6:903-906